BIO-key International, Inc. Shareholders Approve Reverse Stock Split Proposal at Special Meeting

BIO-key International, Inc. (NASDAQ: BKYI) has announced the results of a special meeting of shareholders held on April 20, 2026. The meeting focused on a single, potentially price-sensitive proposal: a reverse stock split of the company’s common stock, which could have significant implications for the company’s share price and future trading dynamics.

Key Points from the Report

• Date of Special Meeting: April 20, 2026
• Company: BIO-key International, Inc. (NASDAQ: BKYI)
• Proposal: An amendment to the company’s Certificate of Incorporation to authorize a reverse stock split of the common stock at a ratio between 1-for-2 and 1-for-10.
• Shareholder Approval: The proposal passed, granting the Board of Directors the authority to implement the reverse split at a ratio and timing of their choosing, but no later than May 6, 2026.
• Quorum and Voting: Out of 10,849,618 shares outstanding as of the record date (March 9, 2026), shareholders holding 5,600,692 shares (51.62%) were present or represented by proxy, constituting a quorum.

Details of the Reverse Stock Split Proposal

The only agenda item at the special meeting was a proposal to amend BIO-key’s Certificate of Incorporation to enable a reverse split of its common stock within a ratio range of 1-for-2 to 1-for-10. The final split ratio and timing are at the discretion of the Board of Directors, following the approval but must occur by May 6, 2026.

Purpose of the Reverse Stock Split: Reverse splits are commonly used to increase a company’s per-share trading price, often to meet minimum bid price requirements for continued listing on major exchanges such as Nasdaq or to make the stock more attractive to institutional investors.

If implemented, this action will reduce the number of outstanding shares and proportionally increase the stock price, although shareholders’ total equity stake remains unchanged. The Board now has flexibility to determine the exact ratio and timing, depending on market conditions and the company’s needs.

Shareholder Voting Results

• Votes For: (Data on actual votes not included in the provided document, but the proposal was approved)
• Votes Against: (Data not specified)
• Abstentions: (Data not specified)
• Broker Non-Votes: (Data not specified)

The passage of this proposal underscores shareholder support for management’s efforts to potentially bolster the company’s stock price and maintain compliance with exchange listing standards.

Potential Impact for Investors and Shareholders

• Price Sensitivity: The approval of a reverse stock split is a material event and can be highly price sensitive. Reverse splits often lead to short-term volatility, and although the intent is generally to support the stock price, the market reaction can vary.
• Exchange Compliance: This move may help BIO-key maintain its Nasdaq Capital Market listing if the share price has fallen below minimum bid requirements.
• Board Discretion: The Board has broad discretion to set the split ratio and timing, which gives management flexibility but also introduces uncertainty regarding the final terms and potential market reaction.
• No Immediate Effect: No reverse split will occur until the Board formally approves the action and announces the effective date and ratio. Investors should monitor company press releases for further updates.

Other Noteworthy Information

• Company Details: BIO-key International, Inc. is incorporated in Delaware and headquartered at 101 Crawfords Corner Rd, Suite 4116, Holmdel, NJ 07733. The company’s primary business is prepackaged software services.
• Trading Symbol: BKYI; listed on the Nasdaq Capital Market.
• Emerging Growth Company Status: BIO-key is not classified as an emerging growth company.

Conclusion

Investor Takeaway: The approval of the reverse stock split proposal is a significant development for BIO-key International, Inc. shareholders. Reverse stock splits are often pursued to maintain exchange listings and can have both positive and negative ramifications for stock price performance in the short and long term. Investors should stay alert for further announcements from the company regarding the implementation details of the reverse split, including the exact ratio and effective date.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own research and consult with professional advisors before making investment decisions. The author and publisher assume no responsibility or liability for any errors or omissions in the content.

View BIO KEY INTERNATIONAL INC Historical chart here